Most Recent

image: Lab-Made Insulin-Secreting Cells

Lab-Made Insulin-Secreting Cells

By | October 13, 2014

Researchers craft hormone-producing pancreas cells from human embryonic stem cells, paving the way for a cell therapy to treat diabetes.

0 Comments

image: All Eyes On Stem Cells

All Eyes On Stem Cells

By | October 1, 2014

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Eyes on the Prize

Eyes on the Prize

By | October 1, 2014

A handful of stem cell therapeutics for vision disorders are showing promise in early-stage trials, and still more are in development. But there’s a long road to travel before patients see real benefit.  

3 Comments

image: Speaking of Vision Science

Speaking of Vision Science

By | October 1, 2014

October 2014's selection of notable quotes

1 Comment

image: Precisely Placed

Precisely Placed

By | September 1, 2014

Vein patterns in the wings of developing fruit flies never vary by more than the width of a single cell.

3 Comments

image: Crayfish Blood Cells Make New Neurons

Crayfish Blood Cells Make New Neurons

By | August 13, 2014

Hemocytes can form neurons in adult crayfish, a study shows.

0 Comments

image: Not All Stem Cells Created Equal

Not All Stem Cells Created Equal

By | July 2, 2014

Compared to induced pluripotent stem cells generated from somatic cells, stem cells created by nuclear transfer appear to be closer to the genetic state of embryonic cells.

1 Comment

image: Arrested Development Makes for Long-Lived Worms

Arrested Development Makes for Long-Lived Worms

By | June 23, 2014

Starvation suspends cellular activity in C. elegans larvae and extends their lifespan. 

0 Comments

image: Autism-Hormone Link Found

Autism-Hormone Link Found

By | June 4, 2014

A study documents boys with autism who were exposed to elevated levels of testosterone, cortisol, and other hormones in utero.

1 Comment

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech